Factors associated with exacerbations in patients with COPD: NOVELTY study
H. Müllerová (Cambridge, United Kingdom), B. Ding (Gothenburg, Sweden), E. Rapsomaniki (Cambridge, United Kingdom), R. Beasley (Wellington, New Zealand), J. Fitzgerald (Vancouver, Canada), T. Harrison (Nottingham, United Kingdom), R. Hughes (Cambridge, United Kingdom), J. Olaguibel (Pamplona, Spain), H. Reddel (Sydney, Australia), P. Varghese (Gaithersburg, MD, United States of America), M. Sadatsafavi (Vancouver, Canada), C. Janson (Uppsala, Sweden)
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Session: COPD and the impact of comorbidities
Session type: E-poster session
Number: 2474
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Müllerová (Cambridge, United Kingdom), B. Ding (Gothenburg, Sweden), E. Rapsomaniki (Cambridge, United Kingdom), R. Beasley (Wellington, New Zealand), J. Fitzgerald (Vancouver, Canada), T. Harrison (Nottingham, United Kingdom), R. Hughes (Cambridge, United Kingdom), J. Olaguibel (Pamplona, Spain), H. Reddel (Sydney, Australia), P. Varghese (Gaithersburg, MD, United States of America), M. Sadatsafavi (Vancouver, Canada), C. Janson (Uppsala, Sweden). Factors associated with exacerbations in patients with COPD: NOVELTY study. 2474
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: